NGVT

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity will participate in a fireside chat at the 2026 Water Tower Research Insights Conference.

Here is how Ingevity (NGVT) and Solstice Advanced Materials (SOLS) have performed compared to their sector so far this year.

NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Ingevity is transforming into a focused, high-margin regulatory compounder, emphasizing Performance Materials and Pavement Technologies after divesting volatile, lower-quality segments. Q2 '26 results highlight margin inflection: adjusted EBITDA rose 14% to $115M, margin expanded to 36.6%, and EPS increased to $1.74, demonstrating strong operating leverage. Hybrid vehicle adoption and infrastructure spending underpin resilient demand for NGVT's emissions-control and pavement solutions, while PFAS filtration offers incremental EBITDA growth optionality.

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.

Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.

Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.